93 related articles for article (PubMed ID: 2064235)
1. Eglin C and heparin inhibition of platelet activation induced by cathepsin G or human neutrophils.
Renesto P; Ferrer-Lopez P; Chignard M
Ann N Y Acad Sci; 1991; 624():321-4. PubMed ID: 2064235
[No Abstract] [Full Text] [Related]
2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
Renesto P; Chignard M
J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
[TBL] [Abstract][Full Text] [Related]
4. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
Evangelista V; Piccardoni P; de Gaetano G; Cerletti C
Thromb Haemost; 1992 Jun; 67(6):660-4. PubMed ID: 1509406
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Eglin c with polymorphonuclear cells: evidence for binding to the cell surface.
Braun NJ; Schnebli HP
Biol Chem Hoppe Seyler; 1987 Feb; 368(2):155-61. PubMed ID: 3566916
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
8. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
Rajtar G; Marchi E; de Gaetano G; Cerletti C
Biochem Pharmacol; 1993 Sep; 46(5):958-60. PubMed ID: 8373448
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
Renesto P; Chignard M
Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217
[TBL] [Abstract][Full Text] [Related]
10. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
Ermolieff J; Boudier C; Laine A; Meyer B; Bieth JG
J Biol Chem; 1994 Nov; 269(47):29502-8. PubMed ID: 7961933
[TBL] [Abstract][Full Text] [Related]
11. Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin.
Ermolieff J; Duranton J; Petitou M; Bieth JG
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1369-74. PubMed ID: 9494108
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G.
Evangelista V; Piccardoni P; Maugeri N; De Gaetano G; Cerletti C
Eur J Pharmacol; 1992 Jun; 216(3):401-5. PubMed ID: 1425930
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
14. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
[TBL] [Abstract][Full Text] [Related]
15. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.
Steinmeyer J; Kalbhen DA
Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.
Glusa E; Adam C
Br J Pharmacol; 2001 Jun; 133(3):422-8. PubMed ID: 11375259
[TBL] [Abstract][Full Text] [Related]
17. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.
Bangalore N; Travis J
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):659-66. PubMed ID: 7888078
[TBL] [Abstract][Full Text] [Related]
18. Modulation by superoxide anions of neutrophil-mediated platelet activation.
Renesto P; Si Tahar M; Chignard M
Biochem Pharmacol; 1994 Apr; 47(8):1401-4. PubMed ID: 8185647
[TBL] [Abstract][Full Text] [Related]
19. Synergism between interleukin-8 and tumor necrosis factor-alpha for neutrophil-mediated platelet activation.
Si Tahar M; Renesto P; Balloy V; Chignard M
Eur Cytokine Netw; 1994; 5(5):455-60. PubMed ID: 7880976
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
Renesto P; Balloy V; Chignard M
Eur J Pharmacol; 1993 Aug; 248(2):151-5. PubMed ID: 8223961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
